This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2984)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Menopause  • Alert me on articles by topic

Stephen Hulley, MD; Deborah Grady, MD; Trudy Bush, PhD; Curt Furberg, MD, PhD; David Herrington, MD; Betty Riggs, MD; Eric Vittinghoff, PhD; for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group

JAMA. 1998;280:605-613.

Context.— Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen than in women who do not, but this potential benefit has not been confirmed in clinical trials.

Objective.— To determine if estrogen plus progestin therapy alters the risk for CHD events in postmenopausal women with established coronary disease.

Design.— Randomized, blinded, placebo-controlled secondary prevention trial.

Setting.— Outpatient and community settings at 20 US clinical centers.

Participants.— A total of 2763 women with coronary disease, younger than 80 years, and postmenopausal with an intact uterus. Mean age was 66.7 years.

Intervention.— Either 0.625 mg of conjugated equine estrogens plus 2.5 mg of medroxyprogesterone acetate in 1 tablet daily (n=1380) or a placebo of identical appearance (n=1383). Follow-up averaged 4.1 years; 82% of those assigned to hormone treatment were taking it at the end of 1 year, and 75% at the end of 3 years.

Main Outcome Measures.— The primary outcome was the occurrence of nonfatal myocardial infarction (MI) or CHD death. Secondary cardiovascular outcomes included coronary revascularization, unstable angina, congestive heart failure, resuscitated cardiac arrest, stroke or transient ischemic attack, and peripheral arterial disease. All-cause mortality was also considered.

Results.— Overall, there were no significant differences between groups in the primary outcome or in any of the secondary cardiovascular outcomes: 172 women in the hormone group and 176 women in the placebo group had MI or CHD death (relative hazard [RH], 0.99; 95% confidence interval [CI], 0.80-1.22). The lack of an overall effect occurred despite a net 11% lower low-density lipoprotein cholesterol level and 10% higher high-density lipoprotein cholesterol level in the hormone group compared with the placebo group (each P<.001). Within the overall null effect, there was a statistically significant time trend, with more CHD events in the hormone group than in the placebo group in year 1 and fewer in years 4 and 5. More women in the hormone group than in the placebo group experienced venous thromboembolic events (34 vs 12; RH, 2.89; 95% CI, 1.50-5.58) and gallbladder disease (84 vs 62; RH, 1.38; 95% CI, 1.00-1.92). There were no significant differences in several other end points for which power was limited, including fracture, cancer, and total mortality (131 vs 123 deaths; RH, 1.08; 95% CI, 0.84-1.38).

Conclusions.— During an average follow-up of 4.1 years, treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease. The treatment did increase the rate of thromboembolic events and gallbladder disease. Based on the finding of no overall cardiovascular benefit and a pattern of early increase in risk of CHD events, we do not recommend starting this treatment for the purpose of secondary prevention of CHD. However, given the favorable pattern of CHD events after several years of therapy, it could be appropriate for women already receiving this treatment to continue.

From the University of California, San Francisco (Drs Hulley, Grady, and Vittinghoff); The Johns Hopkins University, Baltimore, Md (Dr Bush); Wake Forest University School of Medicine, Winston-Salem, NC (Drs Furberg and Herrington); and Wyeth-Ayerst Research, Radnor, Pa (Dr Riggs).

RELATED LETTERS

Early Risks of Hormone Therapy in Patients With Coronary Heart Disease
Nanette K. Wenger, Genell L. Knatterud, and Paul L. Canner
JAMA. 2000;284(1):41-43.
EXTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
The Women's Health Initiative Steering Committee
JAMA. 2004;291(14):1701-1712.
ABSTRACT | FULL TEXT  

RELATED ARTICLE

Hormone Replacement Therapy and Heart Disease Prevention: Experimentation Trumps Observation
Diana B. Petitti
JAMA. 1998;280(7):650-652.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
Suk Danik et al.
J Am Coll Cardiol 2008;52:124-131.
ABSTRACT | FULL TEXT  

Epidemiology of Cytokines: The Women On the Move through Activity and Nutrition (WOMAN) Study
Wong et al.
Am J Epidemiol 2008;0:kwn132v1-kwn132.
ABSTRACT | FULL TEXT  

Oestrogen plays a permissive role in cardioprotection
Cohen and Downey
Cardiovasc Res 2008;0:cvn152v2-2.
FULL TEXT  

Invited Commentary: Postmenopausal Unopposed Estrogen and Breast Cancer Risk in the Women's Health Initiative--Before and Beyond
Linet
Am J Epidemiol 2008;167:1416-1420.
ABSTRACT | FULL TEXT  

Sexual Dimorphism of the Aging Kidney: Role of Nitric Oxide Deficiency
Baylis
Physiology 2008;23:142-150.
ABSTRACT | FULL TEXT  

Osteoporosis: Management and Treatment Strategies for Orthopaedic Surgeons
Gehrig et al.
JBJS 2008;90:1362-1374.
FULL TEXT  

Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
Frempong et al.
J. Clin. Endocrinol. Metab. 2008;93:2097-2103.
ABSTRACT | FULL TEXT  

Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression
Li et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2444-H2455.
ABSTRACT | FULL TEXT  

Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease
Deo et al.
Hypertension 2008;51:1578-1582.
ABSTRACT | FULL TEXT  

Menopausal Complaints Are Associated With Cardiovascular Risk Factors
Gast et al.
Hypertension 2008;51:1492-1498.
ABSTRACT | FULL TEXT  

A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women
Shifren et al.
J. Clin. Endocrinol. Metab. 2008;93:1702-1710.
ABSTRACT | FULL TEXT  

Intracoronary Genistein Acutely Increases Coronary Blood Flow in Anesthetized Pigs through {beta}-Adrenergic Mediated Nitric Oxide Release and Estrogenic Receptors
Grossini et al.
Endocrinology 2008;149:2678-2687.
ABSTRACT | FULL TEXT  

Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats
Brosnihan et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1995-H2001.
ABSTRACT | FULL TEXT  

Persistent Hot Flushes in Older Postmenopausal Women
Huang et al.
Arch Intern Med 2008;168:840-846.
ABSTRACT | FULL TEXT  

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt et al.
BMJ 2008;336:924-926.
FULL TEXT  

Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin
Fu et al.
Mol Hum Reprod 2008;14:225-234.
ABSTRACT | FULL TEXT  

17{beta}-Estradiol Increases Basal but Not Bradykinin-Stimulated Release of Active t-PA in Young Postmenopausal Women
Pretorius et al.
Hypertension 2008;51:1190-1196.
ABSTRACT | FULL TEXT  

Medroxyprogesterone Abrogates the Inhibitory Effects of Estradiol on Vascular Smooth Muscle Cells by Preventing Estradiol Metabolism
Dubey et al.
Hypertension 2008;51:1197-1202.
ABSTRACT | FULL TEXT  

Psychological and Clinical Factors Implicated in Decision Making About a Trial of Low-Dose Tamoxifen in Hormone Replacement Therapy Users
Rondanina et al.
JCO 2008;26:1537-1543.
ABSTRACT | FULL TEXT  

Physiological Concentration of 17{beta}-Estradiol on Sympathetic Reinnervation in Ovariectomized Infarcted Rats
Lee et al.
Endocrinology 2008;149:1205-1213.
ABSTRACT | FULL TEXT  

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
MacLean et al.
ANN INTERN MED 2008;148:197-213.
ABSTRACT | FULL TEXT  

Evidence-based common sense?
Sherman
cfp 2008;54:166-168.
FULL TEXT  

Bon sens fonde sur des donnees probantes?
Sherman
cfp 2008;54:169-171.
FULL TEXT  

Time Since Menopause Influences the Acute and Chronic Effect of Estrogens on Endothelial Function
Vitale et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:348-352.
ABSTRACT | FULL TEXT  

Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression
Hamilton et al.
Physiol. Genomics 2008;32:254-263.
ABSTRACT | FULL TEXT  

Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.
Lavie and Milani
J Am Coll Cardiol 2008;51:56-58.
FULL TEXT  

Can Women Be Identified That Will Derive Considerable Cardiovascular Benefits from Postmenopausal Estrogen Therapy?
Clarkson
J. Clin. Endocrinol. Metab. 2008;93:37-39.
FULL TEXT  

Progressive Diastolic Dysfunction in the Female mRen(2).Lewis Rat: Influence of Salt and Ovarian Hormones
Groban et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2008;63:3-11.
ABSTRACT | FULL TEXT  

A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance
Garg et al.
Nephrol Dial Transplant 2008;23:52-55.
FULL TEXT  

Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens
Gardner et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H198-H204.
ABSTRACT | FULL TEXT  

Differential Dietary Nutrient Intake according to Hormone Replacement Therapy Use: An Underestimated Confounding Factor in Epidemiologic Studies?
Vercambre et al.
Am J Epidemiol 2007;166:1451-1460.
ABSTRACT | FULL TEXT  

Pharmacogenetic Modulation of Combined Hormone Replacement Therapy by Progesterone-Metabolism Genotypes in Postmenopausal Breast Cancer Risk
Rebbeck et al.
Am J Epidemiol 2007;166:1392-1399.
ABSTRACT | FULL TEXT  

Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Khaw et al.
Circulation 2007;116:2694-2701.
ABSTRACT | FULL TEXT  

New findings from non-linear longitudinal modelling of menopausal hormone changes
Dennerstein et al.
Hum Reprod Update 2007;13:551-557.
ABSTRACT | FULL TEXT  

Cannabis use and psychosis: the origins and implications of an association
Macleod
Adv. Psychiatr. Treat. 2007;13:400-411.
ABSTRACT | FULL TEXT  

Regulation of Alternative Splicing of Liver Scavenger Receptor Class B Gene by Estrogen and the Involved Regulatory Splicing Factors
Zhang et al.
Endocrinology 2007;148:5295-5304.
ABSTRACT | FULL TEXT  

Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats
Lujan et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H2799-H2808.
ABSTRACT | FULL TEXT  

Can Computerized Decision Support Help Patients Make Complex Treatment Decisions? A Randomized Controlled Trial of an Individualized Menopause Decision Aid
Col et al.
Med Decis Making 2007;27:585-598.
ABSTRACT  

Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice
Gourdy et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2214-2221.
ABSTRACT | FULL TEXT  

Estrogen Protects Against Increased Blood Pressure in Postpubertal Female Growth Restricted Offspring
Ojeda et al.
Hypertension 2007;50:679-685.
ABSTRACT | FULL TEXT  

Low Serum Testosterone and High Serum Estradiol Associate With Lower Extremity Peripheral Arterial Disease in Elderly Men: The MrOS Study in Sweden
Tivesten et al.
J Am Coll Cardiol 2007;50:1070-1076.
ABSTRACT | FULL TEXT  

2-Methoxyestradiol: A Potential Treatment for Multiple Proliferative Disorders
Dubey et al.
Endocrinology 2007;148:4125-4127.
FULL TEXT  

The Endogenous Estradiol Metabolite 2-Methoxyestradiol Reduces Atherosclerotic Lesion Formation in Female Apolipoprotein E-Deficient Mice
Bourghardt et al.
Endocrinology 2007;148:4128-4132.
ABSTRACT | FULL TEXT  

Invited Commentary: Hormone Therapy and Risk of Coronary Heart Disease Why Renew the Focus on the Early Years of Menopause?
Manson and Bassuk
Am J Epidemiol 2007;166:511-517.
ABSTRACT | FULL TEXT  

Hormones and Heart Disease in Women: The Timing Hypothesis
Barrett-Connor
Am J Epidemiol 2007;166:506-510.
ABSTRACT | FULL TEXT  

Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion
Booth and Lucchesi
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H1408-H1415.
ABSTRACT | FULL TEXT  

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:e1-e157.
FULL TEXT  

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women
Vickers et al.
BMJ 2007;335:239-239.
ABSTRACT | FULL TEXT  

Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Collins et al.
Eur Heart J 2007;28:2028-2040.
ABSTRACT | FULL TEXT  

The Pill and the Pendulum
Schiff
Obstet Gynecol 2007;110:228-229.
FULL TEXT  

Hormone Replacement Therapy and Atherosclerosis in Postmenopausal Women: Does Aging Limit Therapeutic Benefits?
Barton et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1669-1672.
FULL TEXT  

Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study
Atteritano et al.
J. Clin. Endocrinol. Metab. 2007;92:3068-3075.
ABSTRACT | FULL TEXT  

Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women
Lawson et al.
J. Clin. Endocrinol. Metab. 2007;92:3089-3094.
ABSTRACT | FULL TEXT  

Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
Glass et al.
JNCI J Natl Cancer Inst 2007;99:1152-1161.
ABSTRACT | FULL TEXT  

Age Moderates the Short-Term Effects of Transdermal 17{beta}-Estradiol on Endothelium-Dependent Vascular Function in Postmenopausal Women
Sherwood et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1782-1787.
ABSTRACT | FULL TEXT  

Neurocognitive Outcomes Are Not Improved by 17{beta}-Estradiol in Postmenopausal Women Undergoing Cardiac Surgery
Hogue et al.
Stroke 2007;38:2048-2054.
ABSTRACT | FULL TEXT  

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT  

Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials
Anderson et al.
Clin Trials 2007;4:207-217.
ABSTRACT  

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Wittes et al.
Clin Trials 2007;4:218-234.
ABSTRACT  

Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Schumacher et al.
Endocr. Rev. 2007;28:387-439.
ABSTRACT | FULL TEXT  

Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials
Wierman and Kohrt
Reproductive Sciences 2007;14:300-314.
ABSTRACT  

Age alters cerebrovascular inflammation and effects of estrogen
Sunday et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;292:H2333-H2340.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
Rossouw et al.
JAMA 2007;297:1465-1477.
ABSTRACT | FULL TEXT  

Effect of genetic variations in platelet glycoproteins Ib{alpha} and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
Bray et al.
Blood 2007;109:1862-1869.
ABSTRACT | FULL TEXT  

Serum estradiol and risk of stroke in elderly men
Abbott et al.
Neurology 2007;68:563-568.
ABSTRACT | FULL TEXT  

Are Some Types of Hormone Therapy Safer Than Others?: Lessons From the Estrogen and Thromboembolism Risk Study
Rexrode and Manson
Circulation 2007;115:820-822.
FULL TEXT  

Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study
Canonico et al.
Circulation 2007;115:840-845.
ABSTRACT | FULL TEXT  

Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer's Disease
Brewer
Exp. Biol. Med. 2007;232:323-335.
ABSTRACT | FULL TEXT  

Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
Benton et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R723-R730.
ABSTRACT | FULL TEXT  

NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis
Rayner et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R743-R750.
ABSTRACT | FULL TEXT  

Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKC{delta}, PKC{epsilon}, Akt, and GSK3beta
Hunter et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R800-R809.
ABSTRACT | FULL TEXT  

Risk of ischemic stroke and lifetime estrogen exposure
de Lecinana et al.
Neurology 2007;68:33-38.
ABSTRACT | FULL TEXT  

Inquiring minds: Women's approaches to evaluating complementary and alternative therapies for menopausal symptoms
Suter et al.
cfp 2007;53:84-90.
ABSTRACT | FULL TEXT  

Ligand-Selective Interdomain Conformations of Estrogen Receptor-{alpha}
Padron et al.
Mol. Endocrinol. 2007;21:49-61.
ABSTRACT | FULL TEXT  

Evidence, Appropriateness, And Technology Assessment In Cardiology: A Case Study Of Computed Tomography
Redberg
Health Aff (Millwood) 2007;26:86-95.
ABSTRACT | FULL TEXT  

Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells
Monsalve et al.
Cardiovasc Res 2007;73:66-72.
ABSTRACT | FULL TEXT  

Risk Factors for Mortality in Middle-aged Women
Tice et al.
Arch Intern Med 2006;166:2469-2477.
ABSTRACT | FULL TEXT  

Clinical trials bureaucracy: unintended consequences of well-intentioned policy
Califf
Clin Trials 2006;3:496-502.
ABSTRACT  

Pitfalls of the WHIs: Women's Health Initiative
MASTORAKOS et al.
Ann. N. Y. Acad. Sci. 2006;1092:331-340.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy in Breast Cancer Survivors
XYDAKIS et al.
Ann. N. Y. Acad. Sci. 2006;1092:349-360.
ABSTRACT | FULL TEXT  

The Cardiovascular Effects of Selective Estrogen Receptor Modulators
CHRISTODOULAKOS et al.
Ann. N. Y. Acad. Sci. 2006;1092:374-384.
ABSTRACT | FULL TEXT  

Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
Basaria and Dobs
J. Clin. Endocrinol. Metab. 2006;91:4743-4752.
ABSTRACT | FULL TEXT  

Estradiol Increases Apoptosis in Human Coronary Artery Endothelial Cells by Up-Regulating Fas and Fas Ligand Expression
Seli et al.
J. Clin. Endocrinol. Metab. 2006;91:4995-5001.
ABSTRACT | FULL TEXT